ENTRY       D00513                      Drug
NAME        Pindolol (JP18/USP/INN);
            Blocklin-L (TN);
            Carvisken (TN);
            Visken (TN)
PRODUCT
  GENERIC   PINDOLOL (ANI Pharmaceuticals)
            PINDOLOL (Bayshore Pharmaceuticals LLC)
            PINDOLOL (Marlex Pharmaceuticals)
            PINDOLOL (Mylan Pharmaceuticals)
            PINDOLOL (Nostrum Laboratories)
            PINDOLOL (PD-Rx Pharmaceuticals)
            PINDOLOL (PD-Rx Pharmaceuticals)
            PINDOLOL (PD-Rx Pharmaceuticals)
            PINDOLOL (Sun Pharmaceutical Industries)
            PINDOLOL (Zydus Lifesciences Limited)
            PINDOLOL (Zydus Pharmaceuticals USA)
FORMULA     C14H20N2O2
EXACT_MASS  248.1525
MOL_WEIGHT  248.3208
CLASS       Cardiovascular agent
             DG01466  Adrenergic receptor antagonist
              DG01464  beta-Adrenergic receptor antagonist (Beta blocker)
             DG01653  Antiarrhythmics
              DG01806  Class II antiarrhythmic agent
             DG03231  Antihypertensive
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
            Transporter substrate
             DG02854  SLC22A2 substrate
REMARK      Same as: C07445
            Therapeutic category: 2123 2149
            ATC code: C07AA03
            Product: D00513<JP/US>
EFFICACY    Antiarrhythmic, Antihypertensive, Vasodilator, beta-Adrenergic receptor antagonist
  DISEASE   Hypertension [DS:H01633]
COMMENT     Propranolol derivative
TARGET      ADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]
  PATHWAY   hsa04080(153+154+155)  Neuroactive ligand-receptor interaction
            hsa04261(153+154)  Adrenergic signaling in cardiomyocytes
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
            Transporter: SLC22A2 [HSA:6582]
INTERACTION  
STR_MAP     map07037  Antiarrhythmic drugs
            map07214  beta-Adrenergic receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C07 BETA BLOCKING AGENTS
               C07A BETA BLOCKING AGENTS
                C07AA Beta blocking agents, non-selective
                 C07AA03 Pindolol
                  D00513  Pindolol (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Beta-adrenergic Blocking Agents
               Beta-adrenergic Blocking Agents, Other
                Pindolol
                 D00513  Pindolol (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               212  Antiarrhythmic agents
                2123  Beta blockers
                 D00513  Pindolol (JP18/USP/INN)
               214  Antihypertensives
                2149  Others
                 D00513  Pindolol (JP18/USP/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01464  beta-Adrenergic receptor antagonist (Beta blocker)
                D00513  Pindolol
              DG01653  Antiarrhythmics
               DG01806  Class II antiarrhythmic agent
                D00513  Pindolol
              DG03231  Antihypertensive
               D00513  Pindolol
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               D00513  Pindolol
             Transporter substrate
              DG02854  SLC22A2 substrate
               D00513  Pindolol
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG03231  Antihypertensive
               D00513  Pindolol
              DG01653  Antiarrhythmics
               D00513  Pindolol
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRB
                 D00513  Pindolol (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00513  Pindolol
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00513
             Drug transporters
              D00513
DBLINKS     CAS: 13523-86-9
            PubChem: 7847579
            ChEBI: 8214
            LigandBox: D00513
            NIKKAJI: J3.439H
ATOM        18
            1   C8y C    18.9000  -17.2200
            2   C8y C    18.9000  -18.6200
            3   C8y C    20.1600  -16.5200
            4   C8x C    17.5700  -16.8000
            5   N4x N    17.5700  -19.1100
            6   C8x C    20.1600  -19.3200
            7   C8x C    21.3500  -17.2200
            8   O2a O    20.1600  -15.1200
            9   C8x C    16.8000  -17.9200
            10  C8x C    21.3500  -18.6200
            11  C1b C    21.3500  -14.4200
            12  C1c C    22.5400  -15.1200
            13  C1b C    23.8000  -14.4200
            14  O1a O    22.5400  -16.5200
            15  N1b N    24.9900  -15.1200
            16  C1c C    26.1800  -14.4200
            17  C1a C    27.4400  -15.1200
            18  C1a C    26.1800  -13.0200
BOND        19
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 2
            7     3   8 1
            8     4   9 2
            9     6  10 2
            10    8  11 1
            11   11  12 1
            12   12  13 1
            13   12  14 1
            14   13  15 1
            15   15  16 1
            16   16  17 1
            17   16  18 1
            18    5   9 1
            19    7  10 1
///
